NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2080224724

Registered date:17/06/2019

A study to assess the safety and efficacy of ZPL389 with concomitant or intermittent use of TCS and/or TCI in atopic dermatitis patients.

Basic Information

Recruitment status completed
Health condition(s) or Problem(s) studiedAtopic dermatitis
Date of first enrollment17/06/2019
Target sample size36
Countries of recruitmentJapan,Asia except Japan,North America,Europe
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : ZPL389 INN of investigational material : - Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational material : ZPL389 once daily control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcomesafety *Frequency of AEs at Week 32 and Week 116.
Secondary Outcomeefficacy *Investigator's global assessment response.[ Time Frame: Investigator's global assessment rating score up to Week 120 ] *Eczema Area and Severity Index (EASI) score. [ Time Frame: EASI-50/EASI-75 response up to Week 120 ]

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximumNot applicable
GenderBoth
Include criteria*Subjects must give a written, signed and dated informed consent *Subjects with atopic dermatitis who have participated in and completed 16 weeks of treatment in CZPL389A2203 study. *Willing and able to comply with scheduled visits, treatment plan, laboratory tests, diary completion and other study procedures.
Exclude criteria*Inability to use TCS and/or TCI due to history of important side effects of topical medication (e.g., intolerance or hypersensitivity reactions). *Treatment discontinued subject from CZPL389A2203 study. *Any skin disease that would confound the diagnosis or evaluation of atopic dermatitis disease activity.

Related Information

Contact

Public contact
Name
Address
Telephone +81-120-003-293
E-mail
Affiliation
Scientific contact
Name
Address
Telephone +81-120-003-293
E-mail
Affiliation